首页> 外文期刊>International journal of urology: official journal of the Japanese Urological Association >Tissue levels of pyrimidine nucleoside phosphorylase activity in human and rodent bladder cancer and normal bladder tissue.
【24h】

Tissue levels of pyrimidine nucleoside phosphorylase activity in human and rodent bladder cancer and normal bladder tissue.

机译:人和啮齿类膀胱癌以及正常膀胱组织中嘧啶核苷磷酸化酶活性的组织水平。

获取原文
获取原文并翻译 | 示例
       

摘要

OBJECTIVES: To assess the relationship between the tissue levels of pyrimidine nucleoside phosphorylase (PyNpase) and clinicopathological parameters in human bladder cancer and to investigate the PyNpase levels in rat and mouse urinary bladder initiated by N-butyl-N-(4-hydroxybutyl) nitrosamine (BBN). METHODS: The PyNpase levels in tumor tissue, normal tissue adjacent to the tumor, and normal tissue apart from the tumor were measured in 102 patients. Additionally, the PyNpase levels were measured in rat and mouse urinary bladders treated with BBN. RESULT: The PyNpase levels of tumor tissue significantly correlated to the tumor grade and growth pattern (papillaryon-papillary), while stage, multiplicity, and tumor shape (peduncle/sessile) were not independent factors. The low-risk tumor of primary, single, G1-Ta showed significantly low levels of PyNpase. The PyNpase levels in the tumor tissue were significantly higher than those in the normal tissue. The PyNpase levels in the adjacent normal tissue were significantly higher than those in the distant normal tissue. The PyNpase levels in rat bladder tissue were significantly higher in the BBN-treatment groups than in those in the control group, only during the early carcinogenic stage. The PyNpase levels in mouse bladder tissue were significantly higher in BBN-treatment groups than in those in the control group during the whole experiment period. CONCLUSION: Our results indicated that not only tumor tissue but also normal tissue adjacent to the tumor had a potential of angiogenesis for tumor development, and transurethral resection of the bladder tumor with a wide normal margin seems to be a reasonable strategy for decreasing the risk of recurrence.
机译:目的:评估人膀胱癌中嘧啶核苷磷酸化酶(PyNpase)的组织水平与临床病理参数之间的关系,并研究由N-丁基-N-(4-羟丁基)亚硝胺引发的大鼠和小鼠膀胱中PyNpase水平(BBN)。方法:对102例患者的肿瘤组织,邻近肿瘤的正常组织和远离肿瘤的正常组织中的PyNpase水平进行了测定。另外,在用BBN治疗的大鼠和小鼠膀胱中测量PyNpase水平。结果:肿瘤组织的PyNpase水平与肿瘤的等级和生长方式(乳头/非乳头状)显着相关,而分期,多样性和肿瘤形状(花序梗/无柄)不是独立的因素。原发性,单一的G1-Ta的低危肿瘤显示PyNpase水平显着降低。肿瘤组织中的PyNpase水平显着高于正常组织中的PyNpase水平。邻近正常组织中的PyNpase水平显着高于远处正常组织中的PyNpase水平。仅在致癌初期,BBN治疗组大鼠膀胱组织中的PyNpase水平显着高于对照组。在整个实验期间,BBN治疗组小鼠膀胱组织中的PyNpase水平显着高于对照组。结论:我们的结果表明,不仅肿瘤组织,而且邻近肿瘤的正常组织都具有血管生成的潜力,可以发展肿瘤,经尿道切除大范围正常边缘的膀胱肿瘤似乎是降低患癌风险的合理策略。复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号